Akari Therapeutics Plc - ADR

NASDAQ:AKTX   3:59:56 PM EDT
0.16
0.00 (+1.68%)
7:55:54 PM EDT: $0.18 +0.02 (+9.88%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Akari Therapeutics Plc - ADR Stock, NASDAQ:AKTX

75/76 Wimpole Street, London, Greater London W1G 9RT
Phone: +44.20.8004.0261
Number of Employees: 15
http://www.akaritx.com

Description

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in London, the United Kingdom.